Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer
Xiao X. Wei, Stephen Chan, Serena S. Kwek, et al.
Cancer Immunology Research (2016) Vol. 4, Iss. 11, pp. 948-958
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Heme-Derived Metabolic Signals Dictate Immune Responses
Giacomo Canesin, Seyed M. Hejazi, Kenneth D. Swanson, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 70
Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
Alexey V. Baldin, Lyudmila V. Savvateeva, Alexandr V. Bazhin, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 590-590
Open Access | Times Cited: 69
High intratumoral CD8+ T‐cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy
Yuanquan Yang, Kristopher Attwood, Wiam Bshara, et al.
The Prostate (2020) Vol. 81, Iss. 1, pp. 20-28
Open Access | Times Cited: 65
Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma)
Christopher Jakubowski, Nilofer S. Azad
Chinese Clinical Oncology (2020) Vol. 9, Iss. 1, pp. 2-2
Open Access | Times Cited: 46
Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
Hillard M. Lazarus, Katherine Pitts, Tisha Wang, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 14
Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma
Yewen Shi, Tongxin Xie, Bingbing Wang, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 22
EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment
Shilpa Bhatia, Diemmy Nguyen, Laurel B. Darragh, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 21
Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
Aarushi Audhut, Sofie Deschoemaeker, Lize Allonsius, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4037-4037
Open Access | Times Cited: 20
Race-related Differences in Sipuleucel-T Response Among Men with Metastatic Castrate-Resistant Prostate Cancer
Elisabeth I. Heath, Archana Thakur, Wei Chen, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 7, pp. 1715-1725
Open Access | Times Cited: 4
Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer
Wenyi Yan, Yujing Xuan, Rui Wang, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 882-882
Open Access
Evaluation of pro‑ and anti‑tumor effects induced by three colony‑stimulating factors, G‑CSF, GM‑CSF and M‑CSF, in bladder cancer cells: Is G‑CSF a friend of bladder cancer cells?
Shunta Hori, Makito Miyake, Sayuri Onishi, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 26
Use of real-time cellular analysis and Plackett-Burman design to develop the serum-free media for PC-3 prostate cancer cells
Ai Zhao, Fahai Chen, Chunhong Ning, et al.
PLoS ONE (2017) Vol. 12, Iss. 9, pp. e0185470-e0185470
Open Access | Times Cited: 27
Selective inhibition of mTORC1 in tumor vessels increases antitumor immunity
Shan Wang, Ariel Raybuck, Eileen Shiuan, et al.
JCI Insight (2020) Vol. 5, Iss. 15
Open Access | Times Cited: 23
Supplementary granulocyte macrophage colony‐stimulating factor to chemotherapy and programmed death‐ligand 1 blockade decreases local recurrence after surgery in bladder cancer
Makito Miyake, Shunta Hori, Sayuri Ohnishi, et al.
Cancer Science (2019) Vol. 110, Iss. 10, pp. 3315-3327
Open Access | Times Cited: 20
Immune Heterogeneity Between Primary Tumors and Corresponding Metastatic Lesions and Response to Platinum Therapy in Primary Ovarian Cancer
Katharina Dötzer, Friederike Schlüter, Markus B. Schoenberg, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1250-1250
Open Access | Times Cited: 20
Developing New Treatment Options for Castration-Resistant Prostate Cancer and Recurrent Disease
Bo-Ren Wang, Yuan Chen, Wei-Hsiang Kao, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1872-1872
Open Access | Times Cited: 11
Transcriptional Activity and Stability of CD39+CD103+CD8+ T Cells in Human High-Grade Endometrial Cancer
Hagma H. Workel, Nienke van Rooij, Annechien Plat, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3770-3770
Open Access | Times Cited: 15
Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapy
Li Zhang, Jason Cham, James V. Cooley, et al.
Journal of Immunological Methods (2021) Vol. 494, pp. 113041-113041
Open Access | Times Cited: 14
Sargramostim and Immune Checkpoint Inhibitors: Combinatorial Therapeutic Studies in Metastatic Melanoma
Ahmad A. Tarhini, Ila Joshi, F. Μ. Garner
Immunotherapy (2021) Vol. 13, Iss. 12, pp. 1011-1029
Open Access | Times Cited: 13
Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers
Geou‐Yarh Liou
Journal of Immunology Research (2017) Vol. 2017, pp. 1-10
Open Access | Times Cited: 14
IL-2/GM-CSF enhances CXCR3 expression in CAR-T cells via the PI3K/AKT and ERK1/2 pathways
Liwei Liu, Yan Cheng, Fasu Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 9, pp. 5547-5557
Closed Access | Times Cited: 8
Unlocking Immunity: Innovative prostate cancer vaccine strategies
Qiannan Gu, Anning Qi, Ne Wang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113137-113137
Closed Access | Times Cited: 1
Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey‐Holden Prostate Cancer Academy Meeting
Andrea K. Miyahira, Heather H. Cheng, Wassim Abida, et al.
The Prostate (2017) Vol. 77, Iss. 15, pp. 1478-1488
Open Access | Times Cited: 11
Synergistic Therapeutic Effects of Probiotic Lactobacillus casei TD-2 Consumption on GM-CSF-Induced Immune Responses in a Murine Model of Cervical Cancer
Elahe Abdolalipour, Mehran Mahooti, Ali Gorji, et al.
Nutrition and Cancer (2020) Vol. 74, Iss. 1, pp. 372-382
Closed Access | Times Cited: 11
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-lnduced Killer Cells
Giulia Mesiano, Roberta Zini, Giulia Montagner, et al.
Molecular Medicine (2017) Vol. 23, Iss. 1, pp. 235-246
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top